12399456https://www.upal.com.my/zh/feeds/jobFeedKwongwahArray ( [0] => HTTP/1.1 200 OK [1] => Date: Thu, 09 Oct 2025 05:33:59 GMT [2] => Content-Type: text/xml; charset=utf-8 [3] => Connection: close [4] => Cache-Control: no-cache, private [5] => Cache-Control: no-cache, no-store, must-revalidate [6] => Nel: {"report_to":"cf-nel","success_fraction":0.0,"max_age":604800} [7] => x-frame-options: SAMEORIGIN [8] => x-content-type-options: nosniff [9] => x-xss-protection: 1; mode=block [10] => referrer-policy: strict-origin-when-cross-origin [11] => permissions-policy: geolocation=(), microphone=(), camera=() [12] => content-security-policy: default-src * 'unsafe-inline' 'unsafe-eval' data: blob:; script-src * 'unsafe-inline' 'unsafe-eval' data: blob:; style-src * 'unsafe-inline' data:; img-src * data: blob:; font-src * data:; connect-src *; frame-src *; object-src *; media-src *; child-src *; [13] => Server: cloudflare [14] => x-robots-tag: noindex, nofollow, nosnippet, noarchive [15] => strict-transport-security: max-age=31536000; includeSubDomains; preload [16] => expires: Fri, 10 Oct 2025 05:33:59 GMT [17] => vary: Accept-Encoding [18] => Report-To: {"group":"cf-nel","max_age":604800,"endpoints":[{"url":"https://a.nel.cloudflare.com/report/v4?s=2t8hydYDzvBbFgwpAuuEDNY9MW9ZoYGravYtDxhoYU52hFYyr4BSrIPOkwt%2FfI7xrJSfnznZdz861VjXWUkFBJP3rGdEZ3%2BtDMpf2T8%3D"}]} [19] => cf-cache-status: DYNAMIC [20] => Speculation-Rules: "/cdn-cgi/speculation" [21] => Server-Timing: cfCacheStatus;desc="DYNAMIC" [22] => Server-Timing: cfEdge;dur=2,cfOrigin;dur=76 [23] => Set-Cookie: UpalLiveSession=eyJpdiI6ImZrOVIzMGdXOFRZVGd3aHNsVUt2VGc9PSIsInZhbHVlIjoiTVRVN0kydCtpOUgwK215STh3MTBDZ2l3dWZ3MUtabm12YTh3VFhxdlZjKzdCTUZRdnVzb3dZbFhJbmRtaTVZQWJJU2JVR01zNVJSdFM2VkYzYnN6aHc9PSIsIm1hYyI6IjU3MzY1NTJmZTk2ZjNiYTJjMjkwMjEwMzI5ZmJhM2UzMDczM2QxZDZlZmNmOTAyYTZiODU5ZjYzMDI4Y2NmZjQifQ%3D%3D; HttpOnly; Path=/; Max-Age=94608000; Expires=Sun, 08 Oct 2028 05:33:59 GMT [24] => CF-RAY: 98bb819ebd0bd964-KUL [25] => alt-svc: h3=":443"; ma=86400 ) 789

继早前创新开展血浆疗法治疗，中国医疗团队周六成功完成全球首例新冠肺炎双肺移植手术。病人术后已清醒，移植双肺功能氧合良好，生命体征平稳。

根据媒体报道，59岁男患者来自江苏省，1月23日发病，3日后确诊新冠肺炎，经插管、人工心肺机(ECMO)和药物治疗后，连续核酸检测呈阴性，但双肺功能已严重受损。

中国著名肺移植专家、中日友好医院肺移植科主任、南医大无锡市人民医院副院长陈静瑜日前为患者进行双肺移植手术，肺部由脑死亡患者捐赠，在外省获取经高铁转运7小时至无锡。

陈静瑜表示，接受肺移植手术有3个前提条件，包括新冠肺炎患者经呼吸机及人工心肺机维持，双肺呼吸衰竭不可逆，且核酸检测连续多次呈阴性，而其他脏器功能基本正常，全身状况能够承受肺移植手术，方可进行。

他指出，为新冠肺炎患者做手术风险较大，且医护人员要在负压手术室间，全程穿上防护衣做手术，对心理和体力考验极大。医疗团队将密切观察病人，重点探索此类患者的手术前后期管理，做好移植后抗排异、抗感染后续治疗，再总结经验救治更多晚期的新冠肺炎危重症患者。